Associated Papers
Target-stabilized base editors enable robust high-fidelity RNA editing.
Liu T et al.
Nature Communications, 2026
Phylogenetic and structural analysis of Hydra ADAR.
Wilcox XE et al.
Archives of Biochemistry and Biophysics, 2025
Biochemical profiling and structural basis of ADAR1-mediated RNA editing.
Deng X et al.
Molecular Cell, 2025
Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration.
Fry LE et al.
Communications Biology, 2025
Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1.
Karki A et al.
Biochemistry, 2024
Selective Inhibition of ADAR1 Using 8-Azanebularine-Modified RNA Duplexes.
Mendoza HG et al.
Biochemistry, 2023
Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.
Chen KJ et al.
Molecular Carcinogenesis, 2023
36453714 (PubMed )
Supplement: MC-62-348-s002.pdf
Regulation of RNA editing by intracellular acidification.
Malik TN et al.
Nucleic Acids Research, 2021
High-throughput mutagenesis reveals unique structural features of human ADAR1.
Park S et al.
Nature Communications, 2020
RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences.
Fry LE et al.
International Journal of Molecular Sciences, 2020
A Phenotypic Screen for Functional Mutants of Human Adenosine Deaminase Acting on RNA 1.
Wang Y et al.
Acs Chemical Biology, 2015
Select a paper to view details